Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is currently no licensed antiviral treatment available to prevent human CoV infection. The widespread clin...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12293
- Acceso en línea:
- https://doi.org/10.1016/j.biopha.2020.110668
http://hdl.handle.net/20.500.12010/12293
- Palabra clave:
- Remdesivir
Lopinavir/ritonavir
Chloroquine/hydroxychloroquine
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Antiviral mechanism
- Rights
- License
- Abierto (Texto Completo)